1. Home
  2. VALN vs BWAY Comparison

VALN vs BWAY Comparison

Compare VALN & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$6.69

Market Cap

653.3M

Sector

Health Care

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$13.91

Market Cap

578.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VALN
BWAY
Founded
2012
2003
Country
France
Israel
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
653.3M
578.5M
IPO Year
2021
2011

Fundamental Metrics

Financial Performance
Metric
VALN
BWAY
Price
$6.69
$13.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$15.50
$13.25
AVG Volume (30 Days)
81.9K
107.3K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$309.69
Revenue Next Year
$93.87
$26.21
P/E Ratio
N/A
$81.98
Revenue Growth
N/A
N/A
52 Week Low
$4.75
$11.77
52 Week High
$12.23
$26.63

Technical Indicators

Market Signals
Indicator
VALN
BWAY
Relative Strength Index (RSI) 57.83 41.95
Support Level $5.10 $13.98
Resistance Level $7.31 $14.83
Average True Range (ATR) 0.23 0.46
MACD -0.05 -0.03
Stochastic Oscillator 47.78 13.36

Price Performance

Historical Comparison
VALN
BWAY

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: